Impact of Pleural Manometry on Chest Discomfort After Therapeutic Thoracentesis

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 26, 2017

Study Completion Date

March 8, 2019

Conditions
Pleural Effusion
Interventions
OTHER

Manometry-guided thoracentesis

Arm I will undergo a standard of care therapeutic thoracentesis procedure, and in addition include pleural pressure monitoring (via an FDA-approved digital manometer) which is also standard of care but left at the discretion of physicians as per expert recommendations. In this group, the procedure will be stopped when the patient develops symptoms or when all the fluid has been removed, and will also be stopped if the pressure begins to fall quickly in the fluid collection.

OTHER

Symptom-guided thoracentesis

Arm II will undergo a standard of care therapeutic thoracentesis procedure. In this group, the procedure but will be stopped when the patient develops symptoms or when all the fluid has been removed.

Trial Locations (1)

37232

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT02677883 - Impact of Pleural Manometry on Chest Discomfort After Therapeutic Thoracentesis | Biotech Hunter | Biotech Hunter